Skip to content
Certified ManufacturersFor manufacturers

Dabur India Ltd

New Delhi, India

Due-diligence report

Find an accredited testing lab and confirm its scope covers your product and methods.

Dabur India Ltd is a dietary supplement manufacturer in New Delhi, India, certified to NSF/ANSI 455-2, NSF/ANSI 455-3 and NSF/ANSI 455-4 GMP, with 2 manufacturing facilities on NSF’s public NSF/ANSI 455 listing as of November 1, 2026. Listed dosage forms: capsules and tablets.

Website
dabur.com
Facilities listed
2
Last checked

Dosage forms

As listed in the product categories of this company’s NSF/ANSI 455-2 certified facilities.

Certified facilities

Manufacturing (2)

  • Plot No.22, Site-IV, Sahibabad, Ghaziabad, 201010, India

    • Dry Formulation
    • Encapsulation
    • Mixing
    • Packaging/Labeling Operation
    • Packaging/Labeling Operation - Bulk Packaging
    • Packaging/Labeling Operation - Dispensing
    • Packaging/Labeling Operation - Primary Packaging
    • Packaging/Labeling Operation - Secondary Packaging
    • Quality Unit Operations
    • Tablet Compression
    • Warehousing
  • Survey No. 225/4/1, Village Sayli Silvassa, 396240, India

    • Dry Formulation
    • Liquid Formulation
    • Mixing
    • Packaging/Labeling Operation
    • Packaging/Labeling Operation - Bulk Packaging
    • Packaging/Labeling Operation - Primary Packaging
    • Packaging/Labeling Operation - Secondary Packaging
    • Quality Unit Operations
    • Warehousing

How Dabur India Ltd compares

Among the 769 manufacturers we list, as of our last check.

FDA recall records

No food or dietary supplement recall found under the name Dabur India Ltd in FDA’s enforcement reports, as of .

We match FDA records by company name only. A recall listed under a different name won’t appear here, and a different company with the same name could. FDA’s food enforcement records start in June 2012. How we check

FDA inspections

FDA lists 1 food or dietary supplement inspection at a facility matching Dabur India Ltd, in 2016, as of . It found conditions the firm was left to correct.

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Ghaziabad, India

    Listed by FDA as Dabur India Limited, Sahibabad Unit

    4 citations posted:

    • Equipment - design - suitable (21 CFR 111.27(a))
    • Exempted, periodic testing; quality control (21 CFR 111.75(d)(2))
    • Master manufacturing record - specific actions; quality (21 CFR 111.210(h)(3))
    • Batch record - results; testing, examination; batch (21 CFR 111.260(h))
    Full citation text
    • Equipment - design - suitable (21 CFR 111.27(a))

      You did not use equipment or utensils of appropriate design, construction, and workmanship to enable them to be adequately cleaned and properly maintained.

    • Exempted, periodic testing; quality control (21 CFR 111.75(d)(2))

      Your quality control personnel did not review and approve the documentation of why an exempted product specification is met without verification through periodic testing of the finished batch.

    • Master manufacturing record - specific actions; quality (21 CFR 111.210(h)(3))

      The written instructions in your master manufacturing record did not include specific actions necessary to perform and verify points, steps, or stages in the manufacturing process where control is necessary to ensure the quality of the dietary supplement.

    • Batch record - results; testing, examination; batch (21 CFR 111.260(h))

      Your batch production records did not include the results of testing or examination performed during batch production, or a cross-reference to such results.

    FEI 3004326829

We match FDA inspections to companies by facility ZIP code (or city outside the US) and company name, so an inspection filed under a different name won’t appear here. FDA publishes final classifications only, and holds some back while enforcement is pending. Posted citations may differ from FDA’s final findings. FDA Data Dashboard · How we check

What Dabur India Ltd says it offers

From Dabur India Ltd’s own website, checked . Not verified by us.

Services

  • Private labelShow quote“We develop and supply products for sale under Retailers’ own brands.”
    “We develop and supply products for sale under Retailers’ own brands.”

    Source page · seen on

  • Contract manufacturingShow quote“State-of-the-art contract manufacturing capabilities, low minimum orders, industry leading formulae and premium design services comprise the Dabur way of doing business.”
    “State-of-the-art contract manufacturing capabilities, low minimum orders, industry leading formulae and premium design services comprise the Dabur way of doing business.”

    Source page · seen on

  • Low minimumsShow quote“State-of-the-art contract manufacturing capabilities, low minimum orders, industry leading formulae and premium design services comprise the Dabur way of doing business.”
    “State-of-the-art contract manufacturing capabilities, low minimum orders, industry leading formulae and premium design services comprise the Dabur way of doing business.”

    Source page · seen on

Commercial details

  • Ships to: over 120 countries (company website)Show quote“Dabur’s products also have huge presence in the overseas markets and are today available in over 120 countries across the globe.”
    “Dabur’s products also have huge presence in the overseas markets and are today available in over 120 countries across the globe.”

    Source page · seen on

We read the company’s public web pages and keep a claim only when its quote appears on the page. A claim is hidden once we haven’t seen it for 120 days. Spotted something wrong? Tell us · How we collect website claims

What we checked, and what we didn’t

Confirmed from NSF’s public listing

Last checked

  • NSF/ANSI 455-2 GMP certification
  • NSF/ANSI 455-3 GMP certification
  • NSF/ANSI 455-4 GMP certification
  • 2 facility addresses
  • Dosage forms in the certified scope
  • Operations listed for each facility

Not verified by us

  • Minimum order quantity (MOQ): the smallest order they accept
  • Lead times and current capacity
  • Prices
  • Other certifications, like organic, kosher, halal or NSF Certified for Sport
  • Whether they’re taking new clients
  • Conditions inside the facility. We don’t visit or audit facilities.
  • What the company’s own website says it makes and offers, shown above with quotes

Ask about these in your quote request. How we verify

Other capsule manufacturers in India

  1. NSF lists a capsule facility in Noida, India

    Noida, Indiabacfo.com

    • Capsules
    • Liquids
    • Powders
    • Softgels
    • Tablets
    Operations:
    • Coating
    • Liquid formulation
    • Tablet compression
    • Encapsulation
    • +1 more
    NSF/ANSI 455-2checked Nov 1, 2026
  2. NSF lists a capsule facility in Bangaluru, India

    Bangalore, Indiabprl.in

    • Capsules
    • Liquids
    • Oils
    • Powders
    • Tablets
    Operations:
    • Kitting
    • Coating
    • Liquid formulation
    • Tablet compression
    • +2 more
    NSF/ANSI 455-2checked Nov 1, 2026
  3. NSF lists a capsule facility in Bangalore, India

    Bangalore, Indiabiomylz.com

    • Capsules
    • Liquids
    • Powders
    • Tablets
    Operations:
    • Coating
    • Liquid formulation
    • Tablet compression
    • Encapsulation
    • +1 more
    NSF/ANSI 455-2checked Nov 1, 2026
  4. NSF lists a capsule facility in Panchkula, India

    Panchkula, Indiachemicalresources.net

    • Capsules
    • Powders
    Operations:
    • Liquid formulation
    NSF/ANSI 455-2checked Nov 1, 2026
  5. NSF lists a capsule facility in Pithampur, India

    Indore, Indiahnhhealthcare.in

    • Capsules
    • Powders
    • Softgels
    • Tablets
    Operations:
    • Coating
    • Tablet compression
    • Encapsulation
    • Dry formulation
    NSF/ANSI 455-2checked Nov 1, 2026
  6. NSF lists a capsule facility in Verna, India

    Mumbai, Indiamarksanspharma.com

    • Capsules
    • Powders
    • Softgels
    • Tablets
    Operations:
    • Kitting
    • Coating
    • Liquid formulation
    • Tablet compression
    • +2 more
    NSF/ANSI 455-2checked Nov 1, 2026